Posted:
2/18/2026, 11:03:49 PM
Location(s):
Tokyo, Japan
Experience Level(s):
Senior
Field(s):
Growth & Marketing
Position Summary
The Associate Director, NF1 Marketing, Brand Lead will lead the all marketing activities of KOSELUGO brand in Japan as a brand leader. S/he will oversee the development and execution of strategy including disease awareness, patient diagnosis, branded communication, peer-to-peer programming, and non-personal promotion. This is a highly strategic role that requires seasoned commercial acumen, scientific curiosity, and growth mindset. The role also requires close collaboration with Sales, Thought Leader Liaison, Medical Affairs, and other internal functions.
Principal Responsibilities
You will need to have:
We would prefer for you to have:
Education
Date Posted
20-2月-2026Closing Date
30-4月-2026Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.
Website: https://www.alexion.com/
Headquarter Location: Boston, Massachusetts, United States
Employee Count: 1001-5000
Year Founded: 1992
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Therapeutics